Whats new
Whats new.
Baird - Transferring Coverage: Compelling Opportunity for Efti in Phase 3 NSCLC; Rated OP, US$7 PT (Analyst: Colleen Kusy)
March 3rd 2025
For a copy of this research report please contact your Baird advisor
Whats new
March 3rd 2025
For a copy of this research report please contact your Baird advisor